Outcome and treatment of elderly patients with ANCA-associated vasculitis

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 7, 2015, Pages 1128-1135

  Weiner, Maria ^a   Goh, Su Mein ^b   Mohammad, Aladdin J ^c,d   Hruskova, Zdenka ^e   Tanna, Anisha ^f   Bruchfeld, Annette ^g,h   Selga, Daina ⁱ   Chocova, Zdenka ^e   Westman, Kerstin ⁱ   Eriksson, Per ^a   Pusey, Charles D ^f   Tesar, Vladimir ^e   Salama, Alan D ^b   Segelmark, Mårten ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e CHARLES UNIVERSITY   (Czech Republic)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB; STEROID;

AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; DIALYSIS; DISEASE ACTIVITY SCORE; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; VERY ELDERLY; AGE; CLINICAL TRIAL; COMORBIDITY; COMPLICATION; DISEASE COURSE; EUROPE; GRANULOMATOSIS WITH POLYANGIITIS; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MICROSCOPIC POLYANGIITIS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; DISEASE PROGRESSION; EUROPE; FEMALE; GRANULOMATOSIS WITH POLYANGIITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MICROSCOPIC POLYANGIITIS; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84936868304     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00480115     Document Type: Article

References (30)

1. Jennette JC, Falk RJ, Hu P, Xiao H: Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8: 139-160, 2013
2. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR; Pan-Thames Renal Research Group: Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am J Kidney Dis 41: 776-784, 2003
3. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M: Incidence and survival rates inWegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48: 1560-1565, 2009
4. Ntatsaki E, Watts RA, Scott DG: Epidemiology of ANCA associated vasculitis. RheumDis ClinNorthAm36: 447-461, 2010
5. Harper L, Savage CO: ANCA-associated renal vasculitis at the end of the twentieth century—a disease of older patients. Rheumatology (Oxford) 44: 495-501, 2005
6. Chen M, Yu F, Zhang Y, Zhao MH: Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 87: 203-209, 2008
7. Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, Jayne D, Harper L; European Vasculitis Study (EUVAS) Group: Early mortality in systemic vasculitis: Relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69: 1036-1043, 2010
8. Harper L, Morgan MD, Walsh M, Hoglund P, Westman K, Flossmann O, Tesar V, Vanhille P, de Groot K, Luqmani R, Flores- Suarez LF, Watts R, Pusey C, Bruchfeld A, Rasmussen N, Blockmans D, Savage CO, Jayne D; EUVAS investigators: Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: Long-term follow-up. Ann Rheum Dis 71: 955-960, 2012
9. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310-317, 2009
10. Tarzi RM, Pusey CD: Vasculitis: Risks and rewards of treating elderly patients with vasculitis. Nat Rev Nephrol 7: 253-255, 2011
11. Hoganson DD, From AM, Michet CJ: ANCA vasculitis in the elderly. J Clin Rheumatol 14: 78-81, 2008
12. Bomback AS, Appel GB, Radhakrishnan J, Shirazian S, Herlitz LC, Stokes B, D’Agati VD, Markowitz GS: ANCA-associated glomerulonephritis in the very elderly. Kidney Int 79: 757-764, 2011
13. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D: Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007
14. Eriksson P, Jacobsson L, Lindell A, Nilsson JA, Skogh T: Improved outcome in Wegener’s granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts. J Intern Med 265: 496-506, 2009
15. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, Westman K, Luqmani R: Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 66: 283-292, 2007
16. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI: Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival. Am J Kidney Dis 26: 353-361, 1995
17. Westman KW, Selga D, Isberg PE, Bladström A, Olsson H: High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCAassociated vasculitis with renal involvement. J Am Soc Nephrol 14: 2926-2933, 2003
18. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, Höglund P, Jayne D, Luqmani R, Mahr A, Mukhtyar C, Pusey C, Rasmussen N, Stegeman C, Walsh M, Westman K; European Vasculitis Study Group: Long-term patient survival in ANCAassociated vasculitis. Ann Rheum Dis 70: 488-494, 2011
19. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA; European Vasculitis Study Group (EUVAS): Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: A systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 67: 1004-1010, 2008
20. Slot MC, Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 63: 670-677, 2003
21. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221-232, 2010
22. Silva F, Seo P, Schroeder DR, Stone JH, Merkel PA, Hoffman GS, Spiera R, Sebastian JK, Davis JC Jr, St Clair EW, Allen NB, McCune WJ, Ytterberg SR, Specks U; Wegener’s Granulomatosis Etanercept Trial Research Group: Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener’s): Long-term followup of a multicenter longitudinal cohort. Arthritis Rheum 63: 2495-2503, 2011
23. Organization for Economic Cooperation and Development: Life expectancy at birth, total population. Health: Key tables from OECD 2010. No. 11, 2010. Available at: http://dx.doi.org/ 10.1787/20758480-2010-table 8. Accessed May 14, 2015
24. Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Hö glund P, Merkel PA, Pagnoux C, Rasmussen N, Westman K, Jayne DR; French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS): Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: A cluster analysis. Ann Rheum Dis 72: 1003-1010, 2013
25. de Joode AA, Sanders JS, Stegeman CA: Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol 8: 1709-1717, 2013
26. Krafcik SS, Covin RB, Lynch JP 3rd, Sitrin RG: Wegener’s granulomatosis in the elderly. Chest 109: 430-437, 1996
27. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG: Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367: 214-223, 2012
28. Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A: Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. NephrolDial Transplant 18[Suppl 5]: v5-v7, 2003
29. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7: 23-32, 1996
30. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD; European Vasculitis Study Group: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J AmSoc Nephrol 18: 2180-2188, 2007